Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 12, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • Diabetes
  • Page 3

Tag: Diabetes

  • BiotechToday
  • World

Is the frequent prescription of PPI medicines a boon or a bane?

bioxone October 18, 2020October 18, 2020 4

Husna, Amity University Kolkata Proton pump inhibitors (PPIs) are a class of medicines that work on the cells which are lining the stomach, reducing the production of acid in our stomach. They can treat heartburn and gastric acid reflux by irreversibly binding with the Na+ H+ ATPase located on the surface of gastric parietal cells.PPIs […]

Read More
  • BiotechToday
  • World

REVERBα (liver) gene – What about your midnight snack?

bioxone October 12, 2020October 12, 2020

Arpita Adhikary, Amity University Kolkata Circadian rhythm is a 24-hour biological, natural rhythm that controls various regulatory internal mechanism including homeostasis, sleep-wake cycle etc. Different external (jet lag, night shift work, late-night eating) and internal factor (gene mutation, ageing, insomnia) are responsible for disruption of the circadian rhythm. Though rare disruption manages to keep the […]

Read More
  • BiotechToday
  • World

Is Diabetes as dangerous and wicked as COVID-19?

bioxone October 7, 2020October 6, 2020 3

Husna, Amity University Kolkata Diabetes has long been mistaken for being a tame problem with a manageable issue. The most renowned approach in diabetes is to empower experts to create , technologies, algorithms, models and therapies to manage glucose in a definite, controlled condition. Attempts to tackle the issue of diabetes till now are authoritative […]

Read More
  • Biotechnopedia
  • DNA-Tales

Stem Cell Therapy: A New Approach Towards Genetic Disorders

bioxone October 6, 2020October 5, 2020

Shinjini Bandopadhyay, Amity University Kolkata Stem cells possess two fundamental properties: diving repeatedly to make copies of themselves and differentiating to give other types of cells in the body.  They can be divided into— human embryonic stem cells (hESCs) which are pluripotent and can give rise to every cell type in the fully formed body tissue-specific […]

Read More
  • BiotechToday
  • India

Elevated adipose expression of IL-2 modulates obesity-linked metabolic inflammation and insulin resistance

bioxone October 3, 2020October 2, 2020 1

-Surupa Chakraborty, Amity University Kolkata Adipose tissue (AT) is an active endocrine organ which stores excess nutrients as triacylglycerols and releases fatty acids during fasting. It is populated by several immune cells including T cells and macrophages, which help in secretion of a variety of adipokines and chemokines. A cardinal feature of obesity includes the […]

Read More
  • World

New insulin treatment for Type 2 diabetes? Find out.

bioxone September 24, 2020September 24, 2020

Prama Ghosh, Amity University Kolkata Past information has shown that patients with type 2 diabetes would by and large lean toward fewer injections and more prominent adaptability than is typical of the current once-daily insulin treatment. Therefore, decreasing the number of injections might build acknowledgment of and adherence to insulin treatment among patients with type […]

Read More
  • Myth-Lysis

MSG (AJI-NO-MOTO): A threat to health?

bioxone September 19, 2020September 19, 2020

-Soumyadeep Ghosh and Binayak Das, Team bioXone Well, who does not like their food to taste good? If you are too concerned about your physique and BMI, then never mind! Food which looks good and tastes good, is all we need to provide us a day with a happy ending. MSG has been in the […]

Read More
  • Biotechnopedia
  • DNA-Tales
  • FEATURED
  • Latest

Diabetes Mellitus

bioxone September 11, 2020September 11, 2020

–Pratyay Islam, Calcutta Medical College Diabetes mellitus is one of the most commonly seen metabolic disorders observed in humans. The underlying cause for this type of diabetes is defective action or secretion of the endocrine hormone insulin, which leads to a rise in blood glucose levels. It is mainly of two types: 1) Type 1 […]

Read More

Posts navigation

1 2 3

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy